scholarly journals Treating epidermal growth factor receptor-mutated non-small cell lung cancer—is dacomitinib the winner?

2017 ◽  
Vol 6 (S1) ◽  
pp. S88-S91
Author(s):  
Wolfram C. M. Dempke ◽  
Klaus Fenchel
Sign in / Sign up

Export Citation Format

Share Document